The fact that over 2 billion people worldwide still lack access to essential and life-saving medicines is not just a statistic - it's a global failure.
This inequity isn't due to a lack of innovation or medical breakthroughs. Medicines exist. The expertise exists. What's missing is a system capable of delivering these life-saving treatments to the people who need them most. In low- and middle-income countries (LMICs), where over 80 per cent of the world's population live, systemic barriers - regulatory complexity, fragmented supply chains, high cost of capital, and challenges in procurement - prevent millions from accessing even the most basic care.